Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Talaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 41K | Jun 13, 2023 | Direct | ||
Moderna, Inc. | Director | Stock Option (Right to Buy) | 7.56K | May 6, 2024 | Direct | ||
ACCELERON PHARMA INC | Director | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
ALEXION PHARMACEUTICALS, INC. | Director | Common Stock, par value $.0001 per share | 0 | $177.00 | Jul 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | May 6, 2024 | 1 | $0 | 4 | May 7, 2024 | Director |
TALS | Talaris Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
MRNA | Moderna, Inc. | May 3, 2023 | 1 | $0 | 4 | May 5, 2023 | Director |
TALS | Talaris Therapeutics, Inc. | Jul 19, 2022 | 7 | $500K | 4/A | Sep 13, 2022 | Director |
TALS | Talaris Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
MRNA | Moderna, Inc. | May 10, 2022 | 3 | $921 | 4 | May 12, 2022 | Director |
MRNA | Moderna, Inc. | Apr 28, 2022 | 3 | $0 | 4 | May 2, 2022 | Director |
TALS | Talaris Therapeutics, Inc. | Dec 15, 2021 | 1 | $0 | 4 | Dec 16, 2021 | Director |
XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 10 | $0 | 4 | Nov 22, 2021 | Director |
ALXN | ALEXION PHARMACEUTICALS, INC. | Jul 21, 2021 | 1 | $0 | 4 | Jul 23, 2021 | Director |
ALXN | ALEXION PHARMACEUTICALS, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |